Nitro-group-containing drugs

K Nepali, HY Lee, JP Liou - Journal of medicinal chemistry, 2018 - ACS Publications
The nitro group is considered to be a versatile and unique functional group in medicinal
chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues …

Unraveling the Impact of 27-Hydroxycholesterol in autoimmune diseases: exploring promising therapeutic approaches

A Hjazi, M Ahsan, MI Alghamdi, AK Kareem… - … -Research and Practice, 2023 - Elsevier
Abstract The role of 27-hydroxycholesterol (27-OHC) in autoimmune diseases has become
a subject of intense research in recent years. This oxysterol, derived from cholesterol, has …

Entacapone alleviates acute kidney injury by inhibiting ferroptosis

J Yang, X Sun, N Huang, P Li, J He, L Jiang… - The FASEB …, 2022 - Wiley Online Library
Acute kidney injury (AKI) is a common clinical problem and an efficacious treatment is
lacking. Ferroptosis, a newly discovered type of programmed cell death, has been reported …

Evaluating opicapone as add-on treatment to levodopa/DDCI in patients with Parkinson's disease

WH Jost - Neuropsychiatric Disease and Treatment, 2022 - Taylor & Francis
Abstract COMT (catechol-O-methyltransferase) inhibitors are key therapeutic agents in the
management of motor fluctuations (MF) in patients with Parkinson's disease (PD). As …

Phosphine-catalyzed hydroboration of propiolonitriles: access to (E)-1, 2-vinylcyanotrifluoroborate derivatives

J Bowen, C Slebodnick, WL Santos - Chemical Communications, 2022 - pubs.rsc.org
We report an organocatalytic trans hydroboration of 3-substituted-propiolonitriles. In the
presence of catalytic amounts of tributylphosphine and pinacolborane, regioselective …

Deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice

M Kanasaki, SP Srivastava, F Yang, L Xu, S Kudoh… - Scientific reports, 2017 - nature.com
methoxyestradiol (2-ME), an estrogen metabolite generated via catechol-o-
methyltransferase (COMT), is multifunctional methoxy-catechol. Here, we report that COMT …

In vitro and in vivo characterization of Entacapone-loaded nanostructured lipid carriers developed by quality-by-design approach

Y Agrawal, K Patil, H Mahajan, M Potdar, P Joshi… - Drug Delivery, 2022 - Taylor & Francis
Entacapone, a reversible catechol-o-methyl transferase inhibitor, is used to enhance the
action of dopamine agonists by reducing their metabolism and the 'Wearing-off'effects …

Large-scale computational drug repositioning to find treatments for rare diseases

RG Govindaraj, M Naderi, M Singha… - NPJ systems biology …, 2018 - nature.com
Rare, or orphan, diseases are conditions afflicting a small subset of people in a population.
Although these disorders collectively pose significant health care problems, drug companies …

Discovery of Small Molecules as Membrane-Bound Catechol-O-methyltransferase Inhibitors with Interest in Parkinson's Disease: Pharmacophore Modeling …

P Cruz-Vicente, AM Gonçalves, O Ferreira, JA Queiroz… - Pharmaceuticals, 2021 - mdpi.com
A pharmacophore-based virtual screening methodology was used to discover new catechol-
O-methyltransferase (COMT) inhibitors with interest in Parkinson's disease therapy. To do …

[图书][B] Complementary therapies in neurology

BS Oken - 2004 - diglib.globalcollege.edu.et
Complementary therapies in neurology Page 2 Page 3 Complementary Therapies in
Neurology AN EVIDENCE-BASED APPROACH Page 4 . Page 5 Complementary Therapies …